Europe Respiratory Care Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

Europe Respiratory Care Devices Market Trends & Summary

Europe Respiratory Care Devices Market is expected to reach US$ 12.97 billion by 2033 from US$ 6.8 billion in 2024, with a CAGR of 7.45% from 2025 to 2033. Increased respiratory diseases, a growing population of older people, increased pollution, technological advancements, the demand for homecare, and post-COVID-19 consciousness are the key drivers for the respiratory care devices market in Europe. Supportive healthcare infrastructure and government schemes also promote the use and funding of advanced respiratory therapies.

The report Europe Respiratory Care Devices Market & Forecast covers by Device Type (Therapeutic, Monitoring, Diagnostic, Consumables, and accessories), Product Type (Respiratory Consumables, Nebulizers, Oxygen Concentrators, Polysomnography Devices, Pulse oximeters, Mechanical Ventilators, Spirometers, and Others), Application (Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Asthma, Respiratory Distress Syndrome, Cystic Fibrosis, and Others), Countries and Company Analysis 2025-2033.

Europe Respiratory Care Devices Industry Overview

A medical device that helps patients with respiratory issues or breathing issues is referred to as a respiratory care device. Asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and acute respiratory infections are some of the conditions that these devices help diagnose, monitor, and treat. Ventilators, nebulizers, oxygen concentrators, CPAP machines, inhalers, and spirometers are some of the most common respiratory care equipment. They are used in hospitals, clinics, and increasingly homecare environments. New gadgets offer greater patient comfort, automation, and mobility due to technological advances. They are critical for management of respiratory disorders of long-term duration, improving the quality of life, and reducing the rate of hospitalization or admission.

Respiratory care equipment market across Europe is growing because of several interrelated factors. The demand for diagnostic and therapeutic instruments is increasing as a consequence of the significant increase in respiratory illnesses like asthma, COPD, and sleep apnea. The local population's aging increases their vulnerability to respiratory diseases, which propels market growth. Smart inhalers, AI-powered monitoring devices, and portable oxygen concentrators are some of the technological advancements that enhance patient convenience and efficacy of treatment. Hospital reliance is reduced by a growing need for home healthcare, facilitated by small and easy-to-use technology. Broader use and quicker market growth across Europe are also aided by favorable government policies, expenditure on healthcare, and streamlined regulatory frameworks.

Growth Drivers for the Europe Respiratory Care Devices Market

Rising prevalence of respiratory disease

The European respiratory care equipment market is expanding largely because respiratory diseases have become more widespread in the region. The incidence of conditions such as sleep apnea, asthma, and chronic obstructive pulmonary disease (COPD) are increasing in the region. For instance, in Germany, asthma impacts nearly 10% of children and 4-5% of adults. The demand for treatment, monitoring, and diagnostic devices like CPAP machines, nebulizers, oxygen concentrators, and inhalers has risen with the growing incidence of respiratory diseases. Some of the causes that contribute to the prevalence of these diseases include environmental pollution, smoking, urbanization, and aging populations. To effectively manage and treat such prevalent diseases, healthcare systems are therefore relying increasingly on advanced respiratory care devices. The increasing market opportunities for European producers of respiratory care devices are underscored by this increasing demand.

Technological Advancements

The European respiratory care equipment market is growing at a fast rate due to technological innovation. Improved treatment outcomes and compliance from patients are being promoted through innovations such as smart inhalers, mobile nebulizers, and ventilators with integrated AI. For instance, MAGNET GROUP and KoKo, LLC, a British spirometer manufacturer, entered into a three-year deal in March 2022. Under this collaboration, MAGNET GROUP can leverage KoKo's advanced lung function software and diagnostics to improve spirometry and other respiratory testing functionalities. Remote patient management is also becoming more convenient with the use of telemedicine and cloud-based monitoring technologies, especially in homecare environments. Apart from enhancing patient outcomes, these innovations are creating new markets for European device manufacturers.

Ageing Population

One of the prime drivers of Europe's respiratory care equipment market is the aging of the population. As age increases, lung capacity naturally decreases and comorbidities increase, which exposes people to respiratory ailments such as asthma, sleep apnea, and COPD. Based on the European Commission, almost one-fifth (21.6%) of the estimated 449.3 million individuals residing in the EU as of January 1, 2024, were aged 65 years and above. To effectively treat these diseases, there is an increased demand for respiratory care devices, including CPAP machines, nebulizers, and portable oxygen concentrators. In addition to this, older people's preferences for home services promote the implementation of breathing machines that are not difficult to utilize. This movement highlights the extremely important role that respiratory care machinery plays in the improvement of Europeans' quality of life.

Challenges in the Europe Respiratory Care Devices Market

High Cost of Devices

In the European market, the high price of respiratory care equipment is a major obstacle. Advanced devices including CPAP machines, ventilators, and portable oxygen concentrators can have high initial and ongoing costs. Especially for older people on fixed incomes and in lower-income areas, this restricts access. Furthermore, the financial strain on healthcare systems may cause delays in adoption and procurement, particularly in publically financed models. Affordability is therefore still a major obstacle to widespread use and fair healthcare delivery.

Regulatory Hurdles

The market for respiratory care equipment in Europe is severely hampered by regulatory barriers. There are now more stringent standards for clinical evaluation, labeling, and post-market surveillance as a result of the EU Medical Device Regulation (MDR). Although the goal of these laws is to guarantee safety and quality, they have resulted in longer approval times for businesses and higher compliance costs. Smaller businesses in particular struggle to manage these intricate procedures, which can impede innovation and market entry and, in turn, restrict patients' access to cutting-edge respiratory care solutions.

Germany Respiratory Care Devices Market

The market for respiratory care equipment in Germany is growing quickly due to the country's aging population and rising rates of respiratory conditions such asthma, sleep apnea, and COPD. The industry is witnessing technological breakthroughs in devices such smart inhalers, CPAP machines, and portable oxygen concentrators. In March 2022, the Free State of Bavaria awarded EUR 225,000 to researchers from FAU (Germany) and McGill University (Canada) to develop a wearable device that would track the breathing of people with long-term conditions like bronchitis or asthma. This indicates that innovation and digital health solutions are highly valued. Leading businesses that are advancing technology integration and enhancing patient care include Philips Healthcare, ResMed, and Drägerwerk AG. It is anticipated that the emphasis on improving device functionality and accessibility would further assist the market's growth.

France Respiratory Care Devices Market

The market for respiratory care equipment in France is expanding gradually due to the country's aging population and high prevalence of respiratory diseases like COPD and asthma. France has the highest prevalence of asthma at 13.5%, according to a study published in November 2022 by PLOS One, underscoring the substantial health burden. As a result, there is now a greater need for medical and diagnostic equipment such oxygen concentrators, nebulizers, and inhalers. Innovations in technology, like portable and easy-to-use gadgets, are enhancing patient compliance and care results. Leading firms are pushing innovation in respiratory care technologies, and the industry is also benefiting from a strong hospital infrastructure and a growing trend toward homecare options.

United Kingdom Respiratory Care Devices Market

The market for respiratory care equipment in the UK is expanding as a result of an aging population and the rising incidence of respiratory diseases such asthma, COPD, and sleep apnea. Technological advancements in respiratory treatment are propelling this market. For example, Honeywell introduced two NIOSH-certified respiratory products in May 2022 to satisfy the demands of healthcare workers. One of these products is the DC365 Small Surgical N95 Respirator, which is designed for individuals who need a smaller size. Responsive Respiratory also unveiled a new catalog in January 2022 that included items like the Purify O3 Elite Sanitizer for cleaning high-pressure oxygen and PAP accessories. These developments are improving patient outcomes and guaranteeing safety, as is the expanding popularity of homecare alternatives. Leading companies that are advancing technology and expanding the availability of respiratory care devices throughout the UK include Philips Healthcare, ResMed, and Drägerwerk.

Europe Respiratory Care Devices Market Segments:

Application

1. Chronic Obstructive Pulmonary Disease (COPD)
2. Obstructive Sleep Apnea
3. Asthma
4. Respiratory Distress Syndrome
5. Cystic Fibrosis
6. Others

Device Type

1. Therapeutic Devices
2. Monitoring Devices
3. Diagnostic Devices
4. Consumables & Accessories

Product Type

1. Respiratory Consumables
2. Nebulizers
3. Oxygen Concentrators
4. Polysomnography Devices
5. Pulse Oximeter
6. Mechanical Ventilators
7. Spirometers
8. Others

End Users

1. Hospitals
2. Home Care
3. Ambulatory Care

Countries

1. France
2. Germany
3. Italy
4. Spain
5. United Kingdom
6. Belgium
7. Netherlands
8. Russia
9. Poland
10. Greece
11. Norway
12. Romania
13. Portugal
14. Rest of Europe

All companies have been covered from 4 viewpoints:

• Overview
• Key Persons
• Recent Development
• Financial Insights

Company Analysis

1. Medtronic Plc
2. Koninklijke Philips
3. General Electric Company
4. Masimo Corporation
5. ResMedInc
6. Becton, Dickinson and Company
7. Chart Industries Inc
8. Getinge AB

Report Details: